IP Science Limited
USPTO PatentsView assignee record - 7 granted patents across 15 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, IP ranks #35,965 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 15 technology areas.
- #35,965
- of 49,997 US assignees by volume
- Top 35%
- by Innovation Score (40.5/100)
- 10.4
- avg claims per patent
- -25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R35965 · Foreign Corporation #35,965 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #35,965/49,997
- PHOTO-FINISH Invox Belgium
- CPC-FOCUS A61K · 15 areas
- INNOV-PAR 40.5/100
- CLAIMS-PAR 10.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Invox Belgium NV (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How IP’s 40.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around IP
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- IP Science · this assignee
IP Science · this assignee
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows IP's Innovation Score is 40.5/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for IP?
Each dot is one of IP’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). IP’s own 10.4 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where IP's grants concentrate
IP Science Limited is a focused PatentsView assignee: 15 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2016. By volume, IP sits between Invox Belgium NV and IRCAD.
IP's three-year grant acceleration
IP Science Limited shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at IP's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Invox Belgium
Invox Belgium NV
7 patents
- Iogenetics
Iogenetics, LLC
7 patents
- Ionic Solutions
Ionic Solutions Ltd.
7 patents
- Ioxt
Ioxt, LLC
7 patents
- Ipco Germany
Ipco Germany GMBH
7 patents
- IQX
IQX Corp.
7 patents
- Iray Technology
Iray Technology Company Limited
7 patents
- Ircad
IRCAD
7 patents
- IP Science ◀
IP Science Limited
7 patents
What this shows IP holds 7 patents at rank #35,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near IP
By rank, the assignees closest to #35,866 in granted patent volume.
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in IP's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
IP's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 35% higher than 65% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 14.3% |
| 2017 | 2 | 28.6% |
| 2018 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2023 | 2 | 28.6% |
Which technologies does IP Science Limited patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
IP Science Limited's patent record in context - here's where to go next.
- IP Science Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #35,965 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare IP Science Limited against Invox Belgium NV, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.